Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
What Bargain Hunting? Tap 5 Stocks With Rising P/E
01:47pm, Tuesday, 24'th Mar 2020
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
What Bargain Hunting? Tap 5 Stocks With Rising P/E
01:47pm, Tuesday, 24'th Mar 2020
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
Great West Life Assurance Co. Can Purchases New Position in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
08:48am, Tuesday, 24'th Mar 2020
Great West Life Assurance Co. Can purchased a new stake in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 4
Verrica Pharmaceuticals (VRCA) Initiated with a Buy at Needham
08:13pm, Monday, 23'rd Mar 2020
Verrica Pharmaceuticals (VRCA) received a Buy rating and a $20.00 price target from Needham analyst Serge Belanger today. The company's shares closed last
Verrica Pharmaceuticals (VRCA) Initiated with a Buy at Needham
08:13pm, Monday, 23'rd Mar 2020
Verrica Pharmaceuticals (VRCA – Research Report) received a Buy rating and a $20.00 price target from Needham analyst Serge Belanger
What You Must Know About Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Beta Value
10:17am, Monday, 23'rd Mar 2020
If you're interested in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), then you might want to consider its beta (a...
ProShare Advisors LLC Sells 1,785 Shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
10:06am, Monday, 23'rd Mar 2020
ProShare Advisors LLC lessened its stake in shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 10.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Co
Generic Drugs Industry's Prospects Uncertain Amid Coronavirus
02:44pm, Friday, 20'th Mar 2020
Generic Drugs Industry's Prospects Uncertain Amid Coronavirus
Generic Drugs Industry's Prospects Uncertain Amid Coronavirus
02:44pm, Friday, 20'th Mar 2020
Stabilizing prices of generic drugs have led to recovery in the industry. New launches have also provided a boost. However, coronavirus crisis creates an uncertainty for the industry.
Aerie Pharma (AERI) Received its Third Buy in a Row
01:09pm, Friday, 20'th Mar 2020
After H.C. Wainwright and Mizuho Securities gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this time from
Aerie Pharma (AERI) Received its Third Buy in a Row
01:09pm, Friday, 20'th Mar 2020
After H.C. Wainwright and Mizuho Securities gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another
Needham Reaffirms Their Buy Rating on Collegium Pharmaceutical (COLL)
12:59pm, Friday, 20'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL), with a price target of $38.00. The
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
